capeliv
ranbaxy farmacÊutica ltda - capecitabina - outros antineoplasicos
corretal
eurofarma laboratÓrios s.a. - capecitabina - outros antineoplasicos
apecibine
dr. reddys farmacÊutica do brasil ltda - capecitabina - antineoplasicos citotoxicos
capecitabina
dr. reddys farmacÊutica do brasil ltda - capecitabina - antineoplasicos citotoxicos
capecitabina
laboratÓrio quÍmico farmacÊutico bergamo ltda - capecitabina - agentes antineoplÁsicos
xeloda
biopas brasil produtos farmaceuticos ltda - capecitabina - outros antineoplasicos
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasias de estômago - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
farmorubicina
wyeth indÚstria farmacÊutica ltda - cloridrato de epirrubicina - antibioticos antineoplasicos
farmorubicina
laboratÓrios pfizer ltda - antibioticos antineoplasicos
brecila
accord farmacÊutica ltda - cloridrato de epirrubicina - antibioticos antineoplasicos